192 related articles for article (PubMed ID: 30139304)
21. Comparative proteome analysis of Brucella melitensis vaccine strain Rev 1 and a virulent strain, 16M.
Eschenbrenner M; Wagner MA; Horn TA; Kraycer JA; Mujer CV; Hagius S; Elzer P; DelVecchio VG
J Bacteriol; 2002 Sep; 184(18):4962-70. PubMed ID: 12193611
[TBL] [Abstract][Full Text] [Related]
22. Global analysis of Brucella melitensis proteomes.
Mujer CV; Wagner MA; Eschenbrenner M; Horn T; Kraycer JA; Redkar R; Hagius S; Elzer P; Delvecchio VG
Ann N Y Acad Sci; 2002 Oct; 969():97-101. PubMed ID: 12381571
[TBL] [Abstract][Full Text] [Related]
23. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
24. Cell mediated immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence strain Rev. 1.
Higgins JL; Bowen RA; Gonzalez-Juarrero M
Vet Immunol Immunopathol; 2018 Aug; 202():74-84. PubMed ID: 30078602
[TBL] [Abstract][Full Text] [Related]
25. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
[TBL] [Abstract][Full Text] [Related]
26. Deletion of the GI-2 integrase and the wbkA flanking transposase improves the stability of Brucella melitensis Rev 1 vaccine.
Mancilla M; Grilló MJ; de Miguel MJ; López-Goñi I; San-Román B; Zabalza-Baranguá A; Moriyón I
Vet Res; 2013 Oct; 44(1):105. PubMed ID: 24176078
[TBL] [Abstract][Full Text] [Related]
27. Genome sequences of three live attenuated vaccine strains of Brucella species and implications for pathogenesis and differential diagnosis.
Wang Y; Ke Y; Wang Z; Yuan X; Qiu Y; Zhen Q; Xu J; Li T; Wang D; Huang L; Chen Z
J Bacteriol; 2012 Nov; 194(21):6012-3. PubMed ID: 23045513
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a Brucella melitensis mutant deficient in O-polysaccharide export system ATP-binding protein as a rough vaccine candidate.
Wang Z; Niu JR; Wang XL; Wu TL; Cheng J; Lu L; Wu QM
Microbes Infect; 2014 Aug; 16(8):633-9. PubMed ID: 25043564
[TBL] [Abstract][Full Text] [Related]
29. The Genome Sequence of Brucella abortus vaccine strain A19 provides insights on its virulence attenuation compared to Brucella abortus strain 9-941.
Wang S; Zhao X; Sun K; Bateer H; Wang W
Gene; 2022 Jul; 830():146521. PubMed ID: 35447245
[TBL] [Abstract][Full Text] [Related]
30. A Brucella melitensis high-temperature-requirement A (htrA) deletion mutant is attenuated in goats and protects against abortion.
Phillips RW; Elzer PH; Robertson GT; Hagius SD; Walker JV; Fatemi MB; Enright FM; Roop RM
Res Vet Sci; 1997; 63(2):165-7. PubMed ID: 9429252
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1.
Higgins JL; Gonzalez-Juarrero M; Bowen RA
PLoS One; 2017; 12(10):e0185823. PubMed ID: 29028813
[TBL] [Abstract][Full Text] [Related]
32. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
[TBL] [Abstract][Full Text] [Related]
33. The Brucella melitensis M5-90 phosphoglucomutase (PGM) mutant is attenuated and confers protection against wild-type challenge in BALB/c mice.
Zhang Y; Li T; Zhang J; Li Z; Zhang Y; Wang Z; Feng H; Wang Y; Chen C; Zhang H
World J Microbiol Biotechnol; 2016 Apr; 32(4):58. PubMed ID: 26925620
[TBL] [Abstract][Full Text] [Related]
34. Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.
Clapp B; Skyberg JA; Yang X; Thornburg T; Walters N; Pascual DW
Infect Immun; 2011 Oct; 79(10):4165-74. PubMed ID: 21768283
[TBL] [Abstract][Full Text] [Related]
35. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
[TBL] [Abstract][Full Text] [Related]
36. Development of Human Vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing
Bugybayeva D; Ryskeldinova S; Zinina N; Sarmykova M; Assanzhanova N; Kydyrbayev Z; Tabynov K
Biomed Res Int; 2020; 2020():1438928. PubMed ID: 33274194
[TBL] [Abstract][Full Text] [Related]
37. Evaluating the virulence of a Brucella melitensis hemagglutinin gene in the caprine model.
Perry QL; Hagius SD; Walker JV; Elzer PH
Vaccine; 2010 Oct; 28 Suppl 5():F6-11. PubMed ID: 20362205
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of wbkF gene in Brucella abortus RB51WboA leads to increased O-polysaccharide expression and enhanced vaccine efficacy against B. abortus 2308, B. melitensis 16M, and B. suis 1330 in a murine brucellosis model.
Dabral N; Burcham GN; Jain-Gupta N; Sriranganathan N; Vemulapalli R
PLoS One; 2019; 14(3):e0213587. PubMed ID: 30856219
[TBL] [Abstract][Full Text] [Related]
39. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice.
Costa LF; Cabello AL; Batista DFA; Chaki SP; de Figueiredo P; da Paixão TA; Rice-Ficht AC; Ficht TA; Santos RL
Microbiol Immunol; 2020 Nov; 64(11):730-736. PubMed ID: 32965738
[TBL] [Abstract][Full Text] [Related]
40. Statistical procedures for calculating the residual virulence of Brucella abortus strain 19 (S19) and Brucella melitensis strain Rev 1 vaccines in mice: theoretical basis and practical applications.
Pouillot R; Grilló MJ; Alabart JL; Garin-Bastuji B; Blasco JM
Rev Sci Tech; 2003 Dec; 22(3):1051-63. PubMed ID: 15005562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
